EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 21st, 2002 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • Delaware
THIS EMPLOYMENT AGREEMENT is made as of January 28, 2002, (this "Agreement"), by and between IDEXX Laboratories, Inc., a Delaware corporation (the "Company") and Jonathan W. Ayers (the "Executive").
AMENDED AND RESTATED AGREEMENTAmended and Restated Agreement • March 21st, 2002 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances
This Agreement, dated as of October 17, 2001, amends and restates in its entirety the Agreement dated as of August 26, 1999 between IDEXX Laboratories, Inc. ("IDEXX") and David E. Shaw ("Shaw") regarding Shaw's reappointment as Chief Executive Officer of IDEXX, and the planned recruitment and appointment of a person to succeed Shaw as such Chief Executive Officer. In consideration of Shaw's willingness to serve as Chief Executive Officer pending the identification and appointment of a successor (the "Succession"), and to serve as Executive Chairman for a period of time after the Succession, and for other good and valuable consideration, the parties agree as follows:
AgreementAgreement • March 21st, 2002 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances
